Exhibit 2.1 AGREEMENT AND PLAN OF MERGER THIS AGREEMENT (the "Agreement") is made this ____ day of June, 2004, by and between Centroid Consolidated Mines Co., a Nevada corporation ("CCMC"); a wholly-owned California subsidiary to be formed by CCMC...Agreement and Plan of Merger • September 2nd, 2004 • eGENE, INC. • Metal mining • California
OFAgreement of Merger • September 2nd, 2004 • eGENE, INC. • Metal mining
EMPLOYMENT AGREEMENTEmployment Agreement • April 18th, 2007 • eGENE, INC. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), dated as of April 12, 2007 is between eGene, Inc. (“eGene” or “the Company”) and Peter Sheu, a resident of California (“Employee”). This Agreement is intended to confirm the understanding between the Company and Employee with respect to Employee’s future employment by the Company, contingent upon execution of the Agreement and Plan of Merger between QIAGEN North American Holdings, Inc., Electra Merger Sub, Inc., and the Company (the “Merger Agreement”). This Agreement shall become effective (the “Effective Date”) immediately prior to consummation of the merger that is the subject of the Merger Agreement set forth above. If such merger is not consummated, this Agreement shall immediately terminate and be of no force or effect.
First Amendment To Employment Agreement By and Between BioCal Technology, Inc. and Dr. Udo Henseler This First Amendment to Employment Agreement (the "First Amendment") is by and between BioCal Technology, Inc., (the "Company") and Dr. Udo Henseler...Employment Agreement • April 1st, 2005 • eGENE, INC. • Pharmaceutical preparations • Florida
Exhibit 10.2 First Amendment To Employment Agreement By and Between eGene, Inc., (formerly BioCal Technology, Inc.) and Varouj Amirkhanian This First Amendment to the Employment Agreement (the "First Amendment") is by and between eGene, Inc., formerly...Employment Agreement • April 3rd, 2006 • eGENE, INC. • Pharmaceutical preparations • Florida
VOTING AGREEMENTVoting Agreement • April 18th, 2007 • eGENE, INC. • Pharmaceutical preparations • Delaware
This VOTING AGREEMENT, dated as of April 12, 2007 (this “Agreement”), is by and between QIAGEN North American Holdings, Inc., a California corporation (“Parent”), and See Counter Part Signature Pages (“Stockholder”). Capitalized terms used herein but not otherwise defined shall have the meanings set forth in the Merger Agreement (as defined below).
AGREEMENT AND PLAN OF MERGER AMONG QIAGEN NORTH AMERICAN HOLDINGS, INC., ELECTRA MERGER SUB, INC. AND EGENE, INC. Dated as of April 12, 2007Agreement and Plan of Merger • April 18th, 2007 • eGENE, INC. • Pharmaceutical preparations • Delaware
This AGREEMENT AND PLAN OF MERGER (this “Agreement”), is made and entered into as of April 12, 2007 by and among QIAGEN NORTH AMERICAN HOLDINGS, INC., a California corporation (“Parent”), ELECTRA MERGER SUB, INC., a Nevada corporation and wholly owned Subsidiary of Parent (“Merger Sub”), and EGENE, INC., a Nevada corporation (the “Company”). Parent, Merger Sub and the Company are sometimes referred to herein each individually as a “Party” and, collectively, as the “Parties.”
NON-SOLICITATION, CONFIDENTIALITY AND INTELLECTUAL PROPERTY AGREEMENTNon-Solicitation, Confidentiality And • April 18th, 2007 • eGENE, INC. • Pharmaceutical preparations • California
This AGREEMENT (the “Agreement”) is made and entered into as of April 12, 2007, by and among QIAGEN N.V. (“Parent”), eGene, Inc., (the “Company”), and Peter Sheu, an individual (“Covenantor”), and is effective as of the Effective Date. Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to them in the Merger Agreement (as defined below). This Agreement shall become effective (the “Effective Date”) immediately prior to consummation of the merger that is the subject of the Merger Agreement set forth above. If such merger is not consummated, this Agreement shall immediately terminate and be of no force or effect.
ContracteGENE, INC. • April 17th, 2007 • Pharmaceutical preparations
This is a Standard Industrial/Commercial Multi-Tenant Lease-Net for our office space in Irvine, California. It has a term of five (5) years commencing September 1, 2004 and ending August 31, 2009. The base rent is $6,163.08 and has adjustments in each of the five years. For more information on this lease see the attached pdf.
NON-COMPETITION, CONFIDENTIALITY AND ITTELLECTUAL PROPERTY AGREEMENTNon-Competition, Confidentiality And • April 18th, 2007 • eGENE, INC. • Pharmaceutical preparations • California
This AGREEMENT (the “Agreement”) is made and entered into as of April 12, 2007, by and among QIAGEN N.V. (“Parent”), eGene, Inc., (the “Company”), and Varoujan Amirkhanian, an individual (“Covenantor”), and is effective as of the Effective Date. Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to them in the Merger Agreement (as defined below). This Agreement shall become effective (the “Effective Date”) immediately prior to consummation of the merger that is the subject of the Merger Agreement set forth above. If such merger is not consummated, this Agreement shall immediately terminate and be of no force or effect.
Source Code License AgreementSource Code License Agreement • April 17th, 2007 • eGENE, INC. • Pharmaceutical preparations • California
The Source Code License Agreement (the “Agreement”), between eGene, Inc., a Nevada corporation located at 17841 Fitch, Irvine, CA 92614 (“EGENE”) and SciBridge Software, located at 10 Woodbridge Ct, Trabuco Canyon, CA 92679 (“SCIBRIDGE”), is entered into this April 12, 2007 (the “Effective Date”).
Exhibit 10.1 First Amendment To Employment Agreement By and Between BioCal Technology, Inc. and Dr. Ming S. Liu This First Amendment to Employment Agreement (the "First Amendment") is by and between BioCal Technology, Inc., (the "Company") and Dr....Employment Agreement • April 3rd, 2006 • eGENE, INC. • Pharmaceutical preparations • Florida
Exhibit 10 Dissolution Agreement THIS DISSOLUTION AGREEMENT ("Dissolution") is entered into this 31st day of January, 2005 by and among MBC Global, LLC ("MBC") and eGene, Inc, formerly BioCal, Inc. (collectively, "EGEI"). Collectively, MBC and EGEI...10 Dissolution Agreement • February 3rd, 2005 • eGENE, INC. • Pharmaceutical preparations • Illinois
ContracteGENE, INC. • April 17th, 2007 • Pharmaceutical preparations
This is a lease agreement with Hong Kong Yilishen Trading Co., Ltd. to lease an office in Shanghai for the period of five years commencing on January 1, 2007 until December 31, 2011. With the initial monthly lease payments of RMB One Hundred Thousand (100,000) Yuan only. For more information on this lease see the attached pdf.
VOTING AGREEMENTVoting Agreement • April 18th, 2007 • eGENE, INC. • Pharmaceutical preparations • Delaware
This VOTING AGREEMENT, dated as of April 12, 2007 (this “Agreement”), is by and between QIAGEN North American Holdings, Inc., a California corporation (“Parent”), and See the Counterpart Signature Pages (“Stockholder”). Capitalized terms used herein but not otherwise defined shall have the meanings set forth in the Merger Agreement (as defined below).
OPTION TERMINATION AGREEMENTOption Termination Agreement • April 18th, 2007 • eGENE, INC. • Pharmaceutical preparations • California
This Option Termination Agreement (this “Agreement”) is made and entered into by and between eGene, Inc., a Nevada corporation (the “Company”), and the individual signatory to this Agreement (the “Optionee”).
Exhibit 10.3 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT is made this 29th day of November, 2005 (this "Agreement"), between eGene, Inc., ("Employer"), and Peter Sheu ("Employee"), also jointly referred to hereafter as the ("parties"). In...Employment Agreement • April 3rd, 2006 • eGENE, INC. • Pharmaceutical preparations • California
NON-COMPETITION, CONFIDENTIALITY, AND INTELLECTUAL PROPERTY AGREEMENTNon-Competition • April 18th, 2007 • eGENE, INC. • Pharmaceutical preparations • California
This AGREEMENT (the “Agreement”) is made and entered into as of April 12, 2007 (the “Effective Date”), by and among QIAGEN N.V. (“Parent”), eGene, Inc., (the “Company”), and Ming-Sun Liu, an individual (“Covenantor”), and is effective as of the Effective Date. Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to them in the Merger Agreement (as defined below). This Agreement shall become effective (the “Effective Date”) immediately prior to consummation of the merger that is the subject of the Merger Agreement set forth above. If such merger is not consummated, this Agreement shall immediately terminate and be of no force or effect.
